Cargando…

Inhibitory quotient in HIV pharmacology

Detalles Bibliográficos
Autor principal:	la Porte, Charles
Formato:	Online Artículo Texto
Lenguaje:	English
Publicado:	BioMed Central 2010
Materias:	Invited Speaker Presentation
Acceso en línea:	https://www.ncbi.nlm.nih.gov/pmc/articles/PMC3315957/ http://dx.doi.org/10.1186/1742-4690-7-S1-I9

Ejemplares similares

Statistical issues in the analysis of non-pharmacological therapy trials with clustering by care-provider or therapy group
por: Roberts, Chris
Publicado: (2011)

Molecular mechanisms involved in HIV latency and implications for HIV treatment and eradication
por: Alcami, Jose, et al.
Publicado: (2010)

Ageing, metabolism and HIV
por: Capeau, Jacqueline
Publicado: (2010)

Bone ageing and HIV
por: Mallon, Patrick W
Publicado: (2010)

Cardiovascular disease and HIV
por: Martínez, Esteban
Publicado: (2010)

Update on HIV reservoirs
por: Palmer, Sarah
Publicado: (2010)

Update on HIV pandemic
por: Ekstrom, Anna Mia
Publicado: (2012)

HIV prevention by vaccine
por: Gallo, Robert
Publicado: (2012)

HIV controllers: state of the art
por: Lambotte, Olivier
Publicado: (2010)

Ageing with HIV: next challenges
por: Fisher, Martin
Publicado: (2010)

The madness of HIV prevention trials
por: McCormack, S
Publicado: (2015)

Potential inflammatory consequences in HIV controllers
por: Hunt, Peter W, et al.
Publicado: (2010)

Translational research at acute HIV Infection
por: Routy, Jean Pierre
Publicado: (2010)

Accelerated immune senescence in HIV infection
por: Appay, Victor
Publicado: (2010)

HIV/HPV coinfection: state-of-the-art
por: Buonaguro, Franco M
Publicado: (2010)

Impact of HIV minor species and tropism
por: Metzner, Karin
Publicado: (2012)

New drug interactions in HIV and HCV
por: Back, David
Publicado: (2012)

Universal access to anti-HIV therapy
por: Souteyrand, Yves
Publicado: (2012)

Animal models of functional HIV cure
por: Silvestri, Guido
Publicado: (2012)

Primary HIV infection: the French experience
por: Goujard, Cécile
Publicado: (2012)

Liver transplantation in HIV-1-infected patients
por: Miró, José M
Publicado: (2010)

Treatments for persistent HIV infection: the road ahead
por: Margolis, David M
Publicado: (2010)

Immunotherapy in HIV infection; current and future challenges
por: Lévy, Yves
Publicado: (2010)

Gene therapy to cure HIV? Prospects and realities
por: Hütter, Gero
Publicado: (2012)

Anti-latency agents to purge HIV reservoirs
por: Moreno, Santiago
Publicado: (2012)

The ups and downs of HIV-1 gene expression
por: Kiernan, Rosemary E
Publicado: (2009)

Toward an HIV preventive vaccine: problems and prospects
por: Gallo, Robert C
Publicado: (2009)

Host genome influences on susceptibility to HIV-1
por: Telenti, Amalio
Publicado: (2009)

NK Cells and immune activation in HIV-1 infection
por: Goodier, Martin R
Publicado: (2010)

Pre-exposure prophylaxis against HIV: pros and cons
por: Wainberg, Mark
Publicado: (2012)

Immunological and virological aspects of HIV cell-to-cell transfer
por: Schwartz, Olivier
Publicado: (2009)

Role of regulatory T cells in the pathogenesis of HIV-1 infection
por: Lévy, Yves
Publicado: (2009)

Use of new technologies to detect and understand HIV drug resistance
por: Kozal, Michael J
Publicado: (2010)

Progeria, a model for accelerated aging exhibited by HIV patients?
por: Cau, Pierre
Publicado: (2010)

Towards a cure for HIV: a long road ahead
por: Chun, Tae-Wook
Publicado: (2012)

Dynamic interplay between HIV-1 integrase and host cofactors
por: Emiliani, Stéphane
Publicado: (2009)

Novel vaccine and gene therapy approaches against HIV-AIDS
por: Das, A, et al.
Publicado: (2009)

Novel and unexpected cellular partners for HIV-1 integrase and Tat
por: Giacca, Mauro
Publicado: (2009)

Is there a role for cytokine-immune based therapy in HIV disease therapy?
por: Poli, Guido
Publicado: (2010)

Molecular control of HIV - 1 postintegration latency: implications for therapeutic strategies
por: Van Lint, Carine
Publicado: (2012)

Cannot write session to /tmp/vufind_sessions/sess_iiktslm6dlne1bdihprlihnsg8